Rational, high quality laboratory monitoring before, during, and after infusion of prothrombin complex concentrates

Thrombosis Research

Volumn 95, Issue 4 SUPPL. 1, 1999, Pages

  Halbmayer, Walter Michael ^a  

^a Inst für Laboratoriumsmedizin   (Austria)

Author keywords

Laboratory monitoring; Prothrombin complex concentrates; Replacement therapy; Side effects

Indexed keywords

PROTHROMBIN COMPLEX;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; GOOD LABORATORY PRACTICE; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 0032824331     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00081-X     Document Type: Article

References (22)

1. Ménaché D. Prothrombin complex concentrates. clinical use Ann New York Acad Sci. 370:1981;747-775.
2. Seremetis S.V., Aledort L.M. Congenital bleeding disorders - Rational treatment opinions. Drugs. 45:1993;541-547.
3. Makris M., Greaves M., Phillips W.S., Kitchen S., Rosendaal F.R., Preston F.E. Emergency oral anticoagulant reversal. The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost. 77:1997;477-480.
4. Kasper C.K. Clinical use of prothrombin complex concentrates. Report on thromboembolic complications Thromb Diath Haemorrh. 33:1975;640-644.
5. Köhler M., Hellstern P., Müller-Berghaus G., Lechler E. Thromboembolische Komplikationen durch Prothrombinkomplex-Konzentrate. D Ärzteblatt. 25(26):1995;1863-1865.
6. Köhler M., Heiden M., Harbauer G., Miyashita C., Mörsdorf S., Braun B., Emert P., Wenzel E., Rose S., Pindur G. Comparison of different prothrombin complex concentrates - In vitro and in vivo studies. Thromb Res. 60:1990;63-70.
7. Lusher J.M. Prediction and management of adverse events associated with the use of factor-IX complex concentrates. Sem Hemat. 30(Suppl 1):1993;36-40.
8. Limentani S.A., Gowell K.P., Deitcher S.R. High-purity factor IX concentrates for treatment of hemophilia B. Relative purity and thrombogenic potential Acta Haematol. 94(Suppl 1):1995;12-17.
9. Mannucci P.M., Bauer K.A., Gringeri A., Barzegar S., Santagostino E., Tradati F.C., Rosenberg R.D. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate. Br J Haematol. 79:1991;606-611.
10. Mannucci P.M., Bauer K.A., Gringeri A., Barzegar S., Bottasso B., Simioni L., Rosenberg R.D. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. Blood. 76:1990;2540-2545.
11. Duschet P., Seifert W., Halbmayer W.M., Fischer M., Gschnait F. Ischemic venous thrombosis caused by a distinct disturbance of the extrinsic clotting system. J Am Acad Dermatol. 28:1993;831-835.
12. Pelzer H., Schwarz A., Stuber W. Determination of human prothrombin activation fragment F1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 65:1991;153-159.
13. Pelzer H., Schwarz A., Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost. 59:1988;101-106.
14. Wildgoose P., Nemerson Y., Hansen L.L., Nielsen F.E., Glazar S., Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood. 80:1992;25-28.
15. Morrissey J.H., Macik B.G., Neuenschwander P.F., Comp P.C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 81:1993;734-744.
16. Neuenschwander P.F., Morrissey J.H. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Blood. 80:1992;14477-14482.
17. Philippou H., Adami A., Lane D.A., Mac Gregor I.R., Tuddenham E.G.D., Lowe G.D.O., Rumley A., Ludlam C.A. High purity factor IX and prothrombin complex concentrate (PCC). Pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC Thromb Haemost. 76:1996;23-28.
18. Eichinger S., Mannucci P.M., Tradati F., Arbini A.A., Rosengerg R.D., Bauer K.A. Determinants of plasma factor VIIa levels in humans. Blood. 86:1995;3021-3025.
19. Bredbacka S., Blombäck M., Wiman B., Pelzer H. Laboratory methods for detecting disseminated intravascular coagulation (DIC). New aspects Acta Anesthesiol Scand. 37:1993;125-130.
20. Hampton K.K., Preston F.E., Lowe G.D., Walker I., Sampson B. Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate. Br J Haematol. 84:1993;279-284.
21. Philippou H., Adami A., Boisclare M.D., Lane D.A. An ELISA for factor X activation peptide. Application to the investigation of thrombogenesis in cardiopulmonary bypass Br J Haemat. 90:1995;432-437.
22. Boisclare M.D., Lane D.A., Philippou H., Esnouf M.P., Sheikh S., Hunt B., Smith K.J. Mechanism of thrombin generation during surgery and cardiopulmonary bypass. Blood. 82:1993;3350-3357.